This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.
Join Richard L. Fong, PharmD, BCOP from UCSF Helen Diller Family Comprehensive Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic Integrating New Treatment Options for Multiple Myeloma: Focus on Oral Therapies.
Join Richard L. Fong, PharmD, BCOP from UCSF Helen Diller Family Comprehensive Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic Integrating New Treatment Options for Multiple Myeloma: Focus on Oral Therapies.
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive care, and follow-up for patients with myeloma.
Join Jill Burke, MSN, NP, and Noopur Raje, MD, from Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 2017 Nursing Forum: Oncology Nursing in Hematologic Malignancies held in San Francisco, California, on October 6, 2017.
Facebook
X
LinkedIn
Forward
